Ameritas Investment Partners’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.9K Hold
2,317
﹤0.01% 2640
2025
Q4
$14.2K Hold
2,317
﹤0.01% 2786
2025
Q3
$42.7K Hold
2,317
﹤0.01% 2253
2025
Q2
$30.1K Hold
2,317
﹤0.01% 2480
2025
Q1
$24.5K Hold
2,317
﹤0.01% 2460
2024
Q4
$39.3K Hold
2,317
﹤0.01% 2330
2024
Q3
$53.8K Hold
2,317
﹤0.01% 2151
2024
Q2
$56.4K Hold
2,317
﹤0.01% 2084
2024
Q1
$78.2K Hold
2,317
﹤0.01% 1891
2023
Q4
$73.1K Hold
2,317
﹤0.01% 1933
2023
Q3
$59.2K Buy
2,317
+679
+41% +$20.9K ﹤0.01% 1991
2023
Q2
$47K Hold
1,638
﹤0.01% 2092
2023
Q1
$39.3K Hold
1,638
﹤0.01% 2124
2022
Q4
$30.9K Hold
1,638
﹤0.01% 2352
2022
Q3
$24K Hold
1,638
﹤0.01% 2421
2022
Q2
$25K Hold
1,638
﹤0.01% 2427
2022
Q1
$44K Hold
1,638
﹤0.01% 2126
2021
Q4
$61K Hold
1,638
﹤0.01% 2009
2021
Q3
$78K Hold
1,638
﹤0.01% 1844
2021
Q2
$55K Hold
1,638
﹤0.01% 2112
2021
Q1
$68K Sell
1,638
-206
-11% -$12.3K ﹤0.01% 1894
2020
Q4
$80K Buy
1,844
+480
+35% +$32.5K ﹤0.01% 1694
2020
Q3
$59K Buy
1,364
+212
+18% +$10.5K ﹤0.01% 1733
2020
Q2
$54K Buy
+1,152
New +$39.7K ﹤0.01% 1780

Other funds holding ARCT

Ameritas Investment Partners's ARCT Position: Q1 2026 in Review

Ameritas Investment Partners held its Arcturus Therapeutics (ARCT) position steady in Q1 2026 at 2,317 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2640.

Ameritas Investment Partners first reported a position in ARCT in Q2 2020 and has held it in 24 quarters since. The position peaked at $80K in Q4 2020. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

  • Ameritas Investment Partners held 2,317 shares of Arcturus Therapeutics worth $17.9K as of Q1 2026.
  • Ameritas Investment Partners left its Arcturus Therapeutics share count unchanged in Q1 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2640 holding.
  • Ameritas Investment Partners first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 24 quarters since.
  • Ameritas Investment Partners's Arcturus Therapeutics position peaked at $80K in Q4 2020.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.